A Study to Compare Two Different Forms of PF-07081532 in Adults Who Are Overweight or Obese
A Phase 1, Open-Label, 2-Period, 2-Sequence, Crossover Study to Compare the Single-Dose Pharmacokinetics of 2 Different Formulations of PF-07081532 Administered Orally to Adult Participants Who Are Overweight or Obese
Category & Conditions: Diabetes and Metabolic Disorders
Medicine: PF-07081532
ClinicalTrials.gov Identifier (NCT): NCT05677867
Protocol ID: C3991010
PrintDownloadOpen Plain Language Summary Result: Click here